Last reviewed · How we verify
Glucosamine,Chondroitin sulfate,Prednisolone,Chloroquine
Glucosamine,Chondroitin sulfate,Prednisolone,Chloroquine is a Small molecule drug developed by Ardabil University of Medical Sciences. It is currently FDA-approved.
At a glance
| Generic name | Glucosamine,Chondroitin sulfate,Prednisolone,Chloroquine |
|---|---|
| Sponsor | Ardabil University of Medical Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Prednisolone and Chloroquine Add on Therapy in Osteoarthritis of the Knee (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Glucosamine,Chondroitin sulfate,Prednisolone,Chloroquine CI brief — competitive landscape report
- Glucosamine,Chondroitin sulfate,Prednisolone,Chloroquine updates RSS · CI watch RSS
- Ardabil University of Medical Sciences portfolio CI
Frequently asked questions about Glucosamine,Chondroitin sulfate,Prednisolone,Chloroquine
What is Glucosamine,Chondroitin sulfate,Prednisolone,Chloroquine?
Glucosamine,Chondroitin sulfate,Prednisolone,Chloroquine is a Small molecule drug developed by Ardabil University of Medical Sciences.
Who makes Glucosamine,Chondroitin sulfate,Prednisolone,Chloroquine?
Glucosamine,Chondroitin sulfate,Prednisolone,Chloroquine is developed and marketed by Ardabil University of Medical Sciences (see full Ardabil University of Medical Sciences pipeline at /company/ardabil-university-of-medical-sciences).
What development phase is Glucosamine,Chondroitin sulfate,Prednisolone,Chloroquine in?
Glucosamine,Chondroitin sulfate,Prednisolone,Chloroquine is FDA-approved (marketed).